Wilms Joris

Wilms Joris is listed in filings as SVP & CHIEF OPERATING OFFICER at Y-mAbs Therapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 18, 2025, including sale activity. Recent filings connect the profile to Y-mAbs Therapeutics, Inc. (YMAB). The current snapshot covers public activity from Aug 27, 2024 to Sep 18, 2025. Reported amounts are shown as $73.5K to $110.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.